Jiya Acquisition signed an unsecured promissory note for a loan of up to $1.5 million from its sponsor Samsara BioCapital for general working capital.
The note requires cash repayment and is not convertible.
Jiya raised $105 million in a November 2020 IPO and private placement. The SPAC is focused on biopharmaceutical companies. Read more.
